Visual Field Progression and RNFL Change After PreserFlo MicroShunt Implantation

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 12, 2021

Primary Completion Date

September 9, 2024

Study Completion Date

September 9, 2024

Conditions
GlaucomaProgressionSurgery
Interventions
DEVICE

PreserFlo Microshunt

The PreserFlo MicroShunt was invented to create a minimally invasive glaucoma drainage device, that comes close to the eye pressure reduction and safety profile of the current gold standard, the trabeculectomy. Reference: Pinchuk L, Riss I, Batlle JF, Kato YP, Martin JB, Arrieta E, Palmberg P, Parrish RK 2nd, Weber BA, Kwon Y, Parel JM. The development of a micro-shunt made from poly(styrene-block-isobutylene-block-styrene) to treat glaucoma. J Biomed Mater Res B Appl Biomater. 2017 Jan;105(1):211-221. doi: 10.1002/jbm.b.33525. Epub 2015 Sep 18. PMID: 26380916; PMCID: PMC5215625.

Trial Locations (1)

9020

RECRUITING

KlinikumKlagenfurt, Klagenfurt

All Listed Sponsors
collaborator

Medical University of Graz

OTHER

lead

Klinikum Klagenfurt am Wörthersee

OTHER